◆ 会议时间：2025年3月16-19日
◆ 会议地点：葡萄牙 波尔图
.
◆ 会议简介：
2025年欧洲生殖器官感染和肿瘤研究组织(EUROGIN)大会-国际多学科HPV大会将于2025年3月16-19日在葡萄牙波尔图举行。EUROGIN大会将提供一个和主题相关的高质量、创新的科学计划，介绍有关各种HPV相关疾病的最新科学信息，会议的一个主要优势是将聚集来自学术界、专业组织和患者组织的杰出国际代表。多年来EUROGIN大会作为HPV感染和相关癌症领域领先的国际会议之一而赢得了极高的声誉，为多学科的高水平科学交流宣提供了一个平台，宗旨是将科学发现转化为临床实践。
欧洲生殖器官感染和瘤变研究组织(EUROGIN)汇集了从事生殖感染和肿瘤研究的临床医生和科学家。未经本站许可禁止复制转载摘录本站任何内容-领域国际医学会议网(lingyuint.com)。
EUROGIN 2025 - EUropean Research Organisation on Genital Infection and Neoplasia Congress
International Multidisciplinary HPV Congress
Date: March 16-19, 2025
Venue: Porto, Portugal
.
.
摘要征文投稿：
Abstract submission deadline: October 30, 2024
点此提交摘要>>>Submit Abstract>>>
- Abstracts must be submitted through the online submission system;
- Your abstract should not exceed a total of 3,500 characters all sections included:
Background/Objectives, Methods, Results, and Conclusion;
- The title should not be written in upper case (capitals), keep it as short as possible clearly indicating the nature of the investigation;
- Please avoid complex mathematical formulae; the system allows to insert simple tables;
- Abstracts should be structured in at least three sections, clearly mentioned as such: Background/Objectives – Methods – Results (optional) – Conclusions. References may be mentioned;
- All authors (main author and co-authors) should be listed with their last names (family names) and their first name(s). The published version will only mention the initial(s) of the first name(s).ONE author must be identified as the PRESENTER; the presenter commits to registering as a delegate (except if she/he is an invited speaker), to attend the congress and present the abstract;
- Please indicate professional addresses of all authors: Name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. Different affiliations will be automatically numbered;
- Do not indent spaces on the first line of each paragraph. No space should be inserted between paragraphs. Use international standards for scientific articles;
- Only standard abbreviations may be used without definition. Data must be given in units widely used in literature;
- Only essential references should be included and put in brackets at the end of the abstract: Numbers in the text may refer to them;
- Drugs must be identified by their generic names and no company names should be mentioned in the title of the abstract.
For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.
For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.
1. HPV disease and COVID-19
2. Viral and molecular biology
3. Epidemiology and natural history
4. Pathogenesis
5. Immunology
6. HPV prophylactic vaccines
7. HPV therapeutic vaccines
8. Immunotherapy - Immuno-oncology - New treatments
9. HPV testing
10. HPV screening
11. Screening for women difficult to reach
12. Triage of HPV positive women
13. Self-sampling
14. Genotyping
15. Molecular markers
16. Screening methods
17. Methylation
18. Microbiome
19. Serology
20. New technologies
21. Artificial intelligence - Big data - Machine learning
22. Diagnostic procedures / management
23. Risk management
24. Colposcopy
25. Cervical neoplasia
26. Vulvar and vaginal diseases and neoplasia
27. Anal neoplasia
28. Oral HPV infection
29. HPV and oropharynx / Head and neck cancer
30. HPV and associated skin diseases
31. Genital warts
32. HPV transmission
33. Sexually transmitted diseases and HIV infection
34. Conventional therapies
35. Economics and modelling
36. Advocacy, acceptability and psychology
37. Health education
38. Low resource settings
39. Public health
40. Fertility and HPV
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
